| Product Name |
Formoterol EP Impurity E / Formoterol USP Related Compound E
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals, Aromatics, Chiral Standards |
| CAS No |
1616967-26-0 |
| Catalog Number |
GS.41.FOR.05 |
| Chemical Name/Synonyms |
N-(2-Hydroxy-5-(1-hydroxy-2-((1-(4-methoxy-3-methylphenyl)propan-2-yl)amino)ethyl)phenyl)formamide; Formoterol Impurity E (Mixture of Diastereomers); N-[2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxy-3-methylphenyl)propan-2-yl]amino}ethyl)phenyl]formamide; 3-Methyl formoterol; N-[2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxy-3-methylphenyl)propan-2-yl]amino}ethyl)phenyl]formamide (USP); Formoterol Related Compound E (As per USP Commenting Opening 51(5)); 1795136-92-3 (Fumarate Salt) |
| Molecular Weight |
358.43 |
| Molecular Formula |
C20H26N2O4 |
| Purity |
NLT 95 % |
| Applications |
Formoterol, a long-acting β2-adrenergic receptor agonist, is widely used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) |
| Inventory Status |
customized
|
